Literature DB >> 10485655

RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues.

R J Monroe1, K J Seidl, F Gaertner, S Han, F Chen, J Sekiguchi, J Wang, R Ferrini, L Davidson, G Kelsoe, F W Alt.   

Abstract

We generated mice in which a functional RAG2:GFP fusion gene is knocked in to the endogenous RAG2 locus. In bone marrow and thymus, RAG2:GFP expression occurs in appropriate stages of developing B and T cells as well as in immature bone marrow IgM+ B cells. RAG2:GFP also is expressed in IgD+ B cells following cross-linking of IgM on immature IgM+ IgD+ B cells generated in vitro. RAG2:GFP expression is undetectable in most immature splenic B cells; however, in young RAG2:GFP mice, there are substantial numbers of splenic RAG2:GFP+ cells that mostly resemble pre-B cells. The latter population decreases in size with age but reappears following immunization of older RAG2:GFP mice. We discuss the implications of these findings for current models of receptor assembly and diversification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485655     DOI: 10.1016/s1074-7613(00)80095-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  54 in total

Review 1.  Review article: role of the surrogate light chain and the pre-B-cell receptor in mouse B-cell development.

Authors:  I L Mårtensson; R Ceredig
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  RAG2 is regulated differentially in B and T cells by elements 5' of the promoter.

Authors:  R J Monroe; F Chen; R Ferrini; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers.

Authors:  M P Armengol; M Juan; A Lucas-Martín; M T Fernández-Figueras; D Jaraquemada; T Gallart; R Pujol-Borrell
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.

Authors:  P Sabbattini; M Lundgren; A Georgiou; C Chow ; G Warnes; N Dillon
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

Review 5.  Studies of the humoral immune response.

Authors:  G Kelsoe
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

6.  Transcriptional analysis of the B cell germinal center reaction.

Authors:  Ulf Klein; Yuhai Tu; Gustavo A Stolovitzky; Jeffrey L Keller; Joseph Haddad; Vladan Miljkovic; Giorgio Cattoretti; Andrea Califano; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

7.  Deletion of immunoglobulin beta in developing B cells leads to cell death.

Authors:  Eric Meffre; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

8.  Antibody repertoire development in fetal and neonatal piglets. XXII. λ Rearrangement precedes κ rearrangement during B-cell lymphogenesis in swine.

Authors:  Xiuzhu Sun; Nancy Wertz; Kelly Lager; Marek Sinkora; Katerina Stepanova; Gregory Tobin; John E Butler
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

Review 9.  The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.

Authors:  Yu Zhang; Monica Gostissa; Dominic G Hildebrand; Michael S Becker; Cristian Boboila; Roberto Chiarle; Susanna Lewis; Frederick W Alt
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

10.  Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Xiaojian Wang; Angela Boston; Grant Kolar; Stephen M Jackson; Yong-Jun Liu; Virginia Pascual; J Donald Capra; Patrick C Wilson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.